You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Diflunisal - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for diflunisal
Drug Prices for diflunisal

See drug prices for diflunisal

Drug Sales Revenue Trends for diflunisal

See drug sales revenues for diflunisal

Recent Clinical Trials for diflunisal

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bristol-Myers SquibbPhase 1
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all diflunisal clinical trials

Pharmacology for diflunisal
Medical Subject Heading (MeSH) Categories for diflunisal
Anatomical Therapeutic Chemical (ATC) Classes for diflunisal

US Patents and Regulatory Information for diflunisal

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs DIFLUNISAL diflunisal TABLET;ORAL 074400-001 Jul 17, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage Pharma DIFLUNISAL diflunisal TABLET;ORAL 202845-002 Aug 16, 2024 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms DIFLUNISAL diflunisal TABLET;ORAL 203547-001 Jun 16, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva DIFLUNISAL diflunisal TABLET;ORAL 073679-001 Jul 31, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Merck DOLOBID diflunisal TABLET;ORAL 018445-002 Apr 19, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage Pharma DIFLUNISAL diflunisal TABLET;ORAL 202845-001 Mar 8, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dastech Intl DIFLUNISAL diflunisal TABLET;ORAL 073562-001 Nov 27, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for diflunisal

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck DOLOBID diflunisal TABLET;ORAL 018445-001 Apr 19, 1982 ⤷  Sign Up ⤷  Sign Up
Merck DOLOBID diflunisal TABLET;ORAL 018445-002 Apr 19, 1982 ⤷  Sign Up ⤷  Sign Up
Merck DOLOBID diflunisal TABLET;ORAL 018445-002 Apr 19, 1982 ⤷  Sign Up ⤷  Sign Up
Merck DOLOBID diflunisal TABLET;ORAL 018445-001 Apr 19, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.